Hydroxychloroquine pre-exposure prophylaxis to prevent SARS-CoV-2 among health care workers at risk for SARS-CoV-2 exposure: A nonrandomized controlled trial
View ORCID ProfileVanessa N. Raabe, Andrew Fleming, Marie I. Samanovic, Lilin Lai, Hayley M. Belli, Mark J. Mulligan, H. Michael Belmont
doi: https://doi.org/10.1101/2022.07.01.22277058
Vanessa N. Raabe
1Division of Infectious Diseases & Immunology and NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine
MDAndrew Fleming
1Division of Infectious Diseases & Immunology and NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine
2Division of Infectious Diseases & Immunology, Department of Medicine, New York University Long Island School of Medicine
MDMarie I. Samanovic
1Division of Infectious Diseases & Immunology and NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine
Ph. DLilin Lai
1Division of Infectious Diseases & Immunology and NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine
3Emory Vaccine Center, Emory University School of Medicine
MDHayley M. Belli
4Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine
Ph. DMark J. Mulligan
1Division of Infectious Diseases & Immunology and NYU Langone Vaccine Center, Department of Medicine, New York University Grossman School of Medicine
MDH. Michael Belmont
5Department of Rheumatology, Department of Medicine, New York University Grossman School of Medicine
MDData Availability
Individual level data from participants will not be shared to protect the privacy of the participating health care workers.
Posted July 03, 2022.
Hydroxychloroquine pre-exposure prophylaxis to prevent SARS-CoV-2 among health care workers at risk for SARS-CoV-2 exposure: A nonrandomized controlled trial
Vanessa N. Raabe, Andrew Fleming, Marie I. Samanovic, Lilin Lai, Hayley M. Belli, Mark J. Mulligan, H. Michael Belmont
medRxiv 2022.07.01.22277058; doi: https://doi.org/10.1101/2022.07.01.22277058
Hydroxychloroquine pre-exposure prophylaxis to prevent SARS-CoV-2 among health care workers at risk for SARS-CoV-2 exposure: A nonrandomized controlled trial
Vanessa N. Raabe, Andrew Fleming, Marie I. Samanovic, Lilin Lai, Hayley M. Belli, Mark J. Mulligan, H. Michael Belmont
medRxiv 2022.07.01.22277058; doi: https://doi.org/10.1101/2022.07.01.22277058
Subject Area
Subject Areas
- Addiction Medicine (383)
- Allergy and Immunology (699)
- Anesthesia (192)
- Cardiovascular Medicine (2854)
- Dermatology (244)
- Emergency Medicine (430)
- Epidemiology (12563)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4437)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2851)
- Health Policy (1049)
- Hematology (375)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4196)
- Nursing (222)
- Nutrition (617)
- Oncology (2204)
- Ophthalmology (624)
- Orthopedics (254)
- Otolaryngology (318)
- Pain Medicine (268)
- Palliative Medicine (82)
- Pathology (486)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6784)
- Radiology and Imaging (1490)
- Respiratory Medicine (900)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)